Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | May 23, 2022 |
| Target | Entasis Therapeutics |
| Sector | Life Science |
| Buyer(s) | Innoviva |
| Deal Type | Add-on Acquisition |
| Deal Value | 113M USD |
| Advisor(s) | MTS Health Partners (Financial) Covington & Burling (Legal) |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1996 |
| Sector | Life Science |
| Employees | 112 |
| Revenue | 359M USD (2024) |
Innoviva is a biopharmaceutical company with a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. It is focused on the discovery, development, and commercialization of small-molecule medicines across several therapeutic areas, including respiratory disease, bacterial infections, and central nervous system (CNS)/pain. Innoviva was founded in 1996 and is based in Burlingame, California.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science | 1 of 2 |
| Type: Add-on Acquisition | 1 of 2 |
| State: Massachusetts | 1 of 2 |
| Country: United States | 1 of 2 |
| Year: 2022 | 1 of 2 |
| Size (of disclosed) | 2 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-06-02 |
Theravance Biopharma
South San Francisco, California, United States Theravance Biopharma is a biopharmaceutical company with one approved product, VIBATIV® (telavancin), that was discovered and developed internally, a pipeline of internally discovered product candidates and strategic collaborations with pharmaceutical companies. Theravance Biopharma was founded in 2013 and is based in George Town, Caymen Islands. |
Sell | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-07-11 |
La Jolla Pharmaceutical
Waltham, Massachusetts, United States La Jolla Pharmaceutical is a biotechnology company involved in the development of therapeutics for lupus nephritis and other autoimmune diseases. La Jolla Pharmaceutical was founded in 1989 and is based in Waltham, Massachusetts. |
Buy | $149M |
